A detailed history of Cibc World Markets Corp transactions in Cerus Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 16,886 shares of CERS stock, worth $28,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,886
Holding current value
$28,875
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$1.52 - $2.03 $25,666 - $34,278
16,886 New
16,886 $26,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $303M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.